1. What is a biosimilar medicine?
Published: 8th August 2019
1. What is a biosimilar medicine?
This patient toolkit has been developed by ecancer in collaboration with the European Cancer Patient Coalition to provide patients with a comprehensive resource on biosimilar medicines. Six modules provide key information and practical advice to support you in making informed decisions for your treatment.
This e-learning resource is supported through an unrestricted education grant from Pfizer.
0
Comments
In association with
Disclaimer: ecancerpatient has no control over the content of external websites
Disclaimer: ecancerpatient has no control over the content of external websites
New Comment >
Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond.
You must login to post comments.
The views expressed here are not those of ecancer Patient. For more information please view our Privacy Policy.